Certainly, the FDA accepts in silico data, but still only in support of traditional animal preclinical data.
While the FDA has expressed interest in in silico testing for drug research, as of 2020, there are no guidances that allow in silico tests to replace preclinical animal testing in drug development, although in silico data can certainly be submitted in support of animal findings, and may reduce the number of animal experiments that are required.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185927/
Therefore, although the in silico tests were successful, and it’s great that PTX has harnessed advanced ICT, preclinical animal testing still needs to be completed before PTX can start clinical trials, as indicated during the webinar.
I didn’t want anyone gaining the false impression that, with in silico testing successfully completed, human trials could start soon when the company guidance is that the first human trial is still two years away.
- Forums
- ASX - By Stock
- PTX
- Ann: PTX successful immunogenicity testing of OmniCAR
Ann: PTX successful immunogenicity testing of OmniCAR, page-90
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PTX (ASX) to my watchlist
|
|||||
Last
4.7¢ |
Change
-0.002(4.08%) |
Mkt cap ! $37.85M |
Open | High | Low | Value | Volume |
4.9¢ | 5.0¢ | 4.6¢ | $54.50K | 1.134M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 108715 | 4.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 189091 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 108715 | 0.047 |
3 | 249374 | 0.046 |
3 | 220000 | 0.045 |
2 | 106598 | 0.043 |
4 | 352851 | 0.042 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 189091 | 2 |
0.050 | 348310 | 3 |
0.052 | 19230 | 1 |
0.054 | 51093 | 1 |
0.055 | 325000 | 3 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
PTX (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online